PT853617E - Novos derivados de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxalinilo - Google Patents
Novos derivados de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxaliniloInfo
- Publication number
- PT853617E PT853617E PT96929275T PT96929275T PT853617E PT 853617 E PT853617 E PT 853617E PT 96929275 T PT96929275 T PT 96929275T PT 96929275 T PT96929275 T PT 96929275T PT 853617 E PT853617 E PT 853617E
- Authority
- PT
- Portugal
- Prior art keywords
- dioxo
- tetrahydro
- new
- quinoxalinyl derivatives
- quinoxalinyl
- Prior art date
Links
- -1 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOXALINYL Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH247995 | 1995-08-31 | ||
| CH273495 | 1995-09-27 | ||
| CH274795 | 1995-09-28 | ||
| CH121396 | 1996-05-10 | ||
| CH163096 | 1996-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT853617E true PT853617E (pt) | 2004-06-30 |
Family
ID=27508939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96929275T PT853617E (pt) | 1995-08-31 | 1996-08-19 | Novos derivados de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxalinilo |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6080743A (pt) |
| EP (1) | EP0853617B1 (pt) |
| JP (1) | JP3159711B2 (pt) |
| KR (1) | KR100462337B1 (pt) |
| CN (1) | CN1137886C (pt) |
| AR (1) | AR005229A1 (pt) |
| AT (1) | ATE260902T1 (pt) |
| AU (1) | AU705871B2 (pt) |
| BR (1) | BRPI9603626B8 (pt) |
| CA (1) | CA2227851C (pt) |
| CZ (1) | CZ56298A3 (pt) |
| DE (1) | DE69631774T2 (pt) |
| DK (1) | DK0853617T3 (pt) |
| ES (1) | ES2217324T3 (pt) |
| HK (1) | HK1010196A1 (pt) |
| HU (1) | HUP9801676A3 (pt) |
| IL (1) | IL122987A (pt) |
| MY (1) | MY132385A (pt) |
| NO (1) | NO310236B1 (pt) |
| NZ (1) | NZ316497A (pt) |
| PL (1) | PL189637B1 (pt) |
| PT (1) | PT853617E (pt) |
| SI (1) | SI0853617T1 (pt) |
| SK (1) | SK25298A3 (pt) |
| TR (1) | TR199800349T2 (pt) |
| WO (1) | WO1997008155A1 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997046539A1 (en) * | 1996-06-05 | 1997-12-11 | Warner-Lambert Company | Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| IL129394A (en) * | 1996-10-24 | 2002-05-23 | Novartis Ag | Amino-alkaline phosphonic acids are converted |
| AU5367598A (en) * | 1996-11-25 | 1998-06-22 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6172065B1 (en) | 1997-03-04 | 2001-01-09 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6340758B1 (en) | 1997-05-16 | 2002-01-22 | Warner-Lambert Company | Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| US6096744A (en) * | 1998-05-04 | 2000-08-01 | Warner-Lambert Company | Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US7361666B2 (en) | 1999-05-25 | 2008-04-22 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6635661B2 (en) | 2000-05-25 | 2003-10-21 | Sepracor Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6677332B1 (en) | 1999-05-25 | 2004-01-13 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| WO2001092226A1 (en) * | 2000-05-25 | 2001-12-06 | Sepracor, Inc. | Heterocyclic analgesic compounds and method of use thereof |
| US7375136B2 (en) * | 2001-03-08 | 2008-05-20 | Emory University | pH-dependent NMDA receptor antagonists |
| TW200403066A (en) * | 2002-04-30 | 2004-03-01 | Novartis Ag | New uses of substituted aminoalkanephosphonic acids |
| GB0310868D0 (en) * | 2003-05-12 | 2003-06-18 | Novartis Ag | Organic compounds |
| US7524837B2 (en) * | 2003-05-12 | 2009-04-28 | Janssen Pharmaceutica N.V. | Benzotriazapinone salts and methods for using same |
| CN1886389B (zh) * | 2003-09-30 | 2010-07-21 | 詹森药业有限公司 | 喹喔啉化合物 |
| US20060020029A1 (en) * | 2004-07-02 | 2006-01-26 | Shimasaki Craig D | Pharmaceutical compositions from ethnobotanicals |
| UA95788C2 (en) * | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
| AU2008272964A1 (en) * | 2007-06-29 | 2009-01-08 | Emory University | NMDA receptor antagonists for neuroprotection |
| CN102906085A (zh) * | 2010-05-20 | 2013-01-30 | 诺瓦提斯公司 | 2,4-二氧代-1,4-二氢-2h-喹唑啉-3-基-磺酰胺衍生物 |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| JO3225B1 (ar) * | 2012-11-27 | 2018-03-08 | Lilly Co Eli | 6-((s)-1-{1-[5-(2-هيدروكسي-إيثوكسي)-بيريدين-2-يل]-1h-بيرازول-3-يل}إيثيل)-3h-1 ، 3-بنزو ثيازول-2- أون باعتباره مضاد مستقبل ampa يعتمد على tarp- جاما 8 |
| CN103435561B (zh) * | 2013-08-19 | 2016-08-10 | 上海交通大学 | 一种新型d-氨基酸氧化酶抑制剂及其制备和应用 |
| KR20190112292A (ko) | 2017-01-27 | 2019-10-04 | 장피트 | 자가 면역 질환을 치료하기 위한 ror-감마 조절 인자로서의 n-｛[2-(피페리딘-1-일)페닐](페닐)메틸｝-2-(3-옥소-3,4-디하이드로-2h-1,4-벤족사진-7-일)아세트아미드 유도체 및 관련 화합물 |
| CN110996948A (zh) | 2017-06-12 | 2020-04-10 | 格莱泰施有限责任公司 | 用nmda拮抗剂和d2/5ht2a或选择性5ht2a拮抗剂治疗抑郁症 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156734A (en) * | 1976-02-13 | 1979-05-29 | Merck & Co., Inc. | Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid |
| CA2002864C (en) * | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
| EP0484437A4 (en) * | 1989-07-27 | 1994-06-01 | Searle & Co | Renal-selective prodrugs for the treatment of hypertension |
| US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| GB9418443D0 (en) * | 1994-09-13 | 1994-11-02 | Pfizer Ltd | Therapeutic agents |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
-
1996
- 1996-08-12 MY MYPI96003300A patent/MY132385A/en unknown
- 1996-08-19 JP JP50980197A patent/JP3159711B2/ja not_active Expired - Fee Related
- 1996-08-19 DE DE69631774T patent/DE69631774T2/de not_active Expired - Lifetime
- 1996-08-19 EP EP96929275A patent/EP0853617B1/en not_active Expired - Lifetime
- 1996-08-19 AU AU68742/96A patent/AU705871B2/en not_active Ceased
- 1996-08-19 PL PL96324992A patent/PL189637B1/pl not_active IP Right Cessation
- 1996-08-19 ES ES96929275T patent/ES2217324T3/es not_active Expired - Lifetime
- 1996-08-19 AT AT96929275T patent/ATE260902T1/de active
- 1996-08-19 CN CNB961965819A patent/CN1137886C/zh not_active Expired - Fee Related
- 1996-08-19 KR KR10-1998-0701511A patent/KR100462337B1/ko not_active IP Right Cessation
- 1996-08-19 NZ NZ316497A patent/NZ316497A/xx unknown
- 1996-08-19 HU HU9801676A patent/HUP9801676A3/hu unknown
- 1996-08-19 US US09/029,525 patent/US6080743A/en not_active Expired - Lifetime
- 1996-08-19 DK DK96929275T patent/DK0853617T3/da active
- 1996-08-19 SI SI9630678T patent/SI0853617T1/xx unknown
- 1996-08-19 SK SK252-98A patent/SK25298A3/sk unknown
- 1996-08-19 CA CA002227851A patent/CA2227851C/en not_active Expired - Fee Related
- 1996-08-19 WO PCT/EP1996/003644 patent/WO1997008155A1/en not_active Application Discontinuation
- 1996-08-19 CZ CZ98562A patent/CZ56298A3/cs unknown
- 1996-08-19 PT PT96929275T patent/PT853617E/pt unknown
- 1996-08-19 TR TR1998/00349T patent/TR199800349T2/xx unknown
- 1996-08-19 IL IL12298796A patent/IL122987A/en not_active IP Right Cessation
- 1996-08-30 AR ARP960104160A patent/AR005229A1/es active IP Right Grant
- 1996-08-30 BR BRPI9603626A patent/BRPI9603626B8/pt not_active IP Right Cessation
-
1998
- 1998-02-26 NO NO19980814A patent/NO310236B1/no unknown
- 1998-10-16 HK HK98111287A patent/HK1010196A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT853617E (pt) | Novos derivados de 2,3-dioxo-1,2,3,4-tetrahidro-quinoxalinilo | |
| DE59605821D1 (de) | l/4-SCALLABSORBER | |
| DE69617978D1 (de) | Achsschenkel | |
| FR2735198B1 (fr) | Piece d'accastillage de type manille-cosse | |
| BR9506532A (pt) | 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas | |
| BR9609884A (pt) | N-aril- 1,2,4-triazolin-5-onas | |
| DE69618634T2 (de) | 1,4-benzodioxin-derivate | |
| NO961404D0 (no) | 4-indolylpiperazinyl-derivater | |
| BR9507892A (pt) | Novos derivados de diamino-metilideno | |
| NO960353L (no) | 4-aminobenzoylguanidinderivater | |
| DE69622415D1 (de) | 12H-Dibenzo[d,g][1,3]dioxocin Derivate | |
| NO960392D0 (no) | 4-merkaptobenzoylguanidinderivater | |
| BR9509877A (pt) | Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano | |
| PT796843E (pt) | Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol | |
| NO962931D0 (no) | N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat | |
| BR9510036A (pt) | Derivados de 1,3,4-oxadiazina | |
| BR9508248A (pt) | 1,2,4,6-Tiatriazinas herbicidas | |
| DE59606037D1 (de) | Verbindungsstelle | |
| KR970009963U (ko) | 2축형 경첩 | |
| FR2735986B3 (fr) | Prolongateur d'haltere | |
| BR9610047A (pt) | 1,3,4-oxadiazolin-2-onas | |
| ZA967322B (en) | Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives. | |
| UA10890A (uk) | Мікроіh'єктор | |
| KR970009964U (ko) | 2축형 경첩 | |
| KR970009965U (ko) | 2축형 경첩 |